[-] Show simple item record

dc.contributor.authorKaysin, Alexandereng
dc.contributor.authorMounsey, Anneeng
dc.contributor.otherFamily Physicians Inquiries Networkeng
dc.date.issued2016-04eng
dc.description.abstractResistant hypertension? Time to consider this fourth-line drug For most adults with resistant hypertension, spironolactone is superior to doxazosin and bisoprolol as an adjunct to triple therapy. Practice changer: When a triple regimen of an ACE inhibitor or ARB, calcium channel blocker, and a thiazide diuretic fails to achieve the target blood pressure, try adding spironolactone.eng
dc.identifier.citationJournal of Family Practice, 65(04) 2016: 266-268.eng
dc.identifier.urihttps://hdl.handle.net/10355/48434
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofPriority Updates to Research Literature (PURLs)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjecthypertension ; resistant hypertension ; treatment ; drug therapy ; spironolactone ; doxazosin ; bisoprolol ; ACE inhibitor ; ARGeng
dc.titleResistant hypertension? Time to consider this fourth-line drugeng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record